[go: up one dir, main page]

BR9909844A - Processo para sintetizar um composto, e, composto. - Google Patents

Processo para sintetizar um composto, e, composto.

Info

Publication number
BR9909844A
BR9909844A BR9909844-0A BR9909844A BR9909844A BR 9909844 A BR9909844 A BR 9909844A BR 9909844 A BR9909844 A BR 9909844A BR 9909844 A BR9909844 A BR 9909844A
Authority
BR
Brazil
Prior art keywords
compound
synthesizing
cyclooxygenase
useful
formula
Prior art date
Application number
BR9909844-0A
Other languages
English (en)
Other versions
BR9909844B1 (pt
Inventor
Edward G Corley
Ian W Davies
Robert D Larsen
Philip J Pye
Kai Rossen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to BRPI9917739A priority Critical patent/BRPI9917739B8/pt
Publication of BR9909844A publication Critical patent/BR9909844A/pt
Publication of BR9909844B1 publication Critical patent/BR9909844B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/30—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having nitrogen atoms of imino groups quaternised

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"PROCESSO PARA SINTETIZAR UM COMPOSTO, E, COMPOSTO" A invenção abrange um processo para preparar compostos de fórmula (I): úteis no tratamento de doenças mediadas por cicloxigenase-2.
BRPI9909844-0A 1998-04-24 1999-04-20 processo de preparação de compostos inibidores de cox-2. BR9909844B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI9917739A BRPI9917739B8 (pt) 1998-04-24 1999-04-20 composto intermediário na preparação de inibidores de cox-2

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8288898P 1998-04-24 1998-04-24
US8566898P 1998-05-15 1998-05-15
PCT/US1999/008645 WO1999055830A2 (en) 1998-04-24 1999-04-20 Process for synthesizing cox-2 inhibitors

Publications (2)

Publication Number Publication Date
BR9909844A true BR9909844A (pt) 2001-04-03
BR9909844B1 BR9909844B1 (pt) 2010-10-19

Family

ID=26767964

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI9917739A BRPI9917739B8 (pt) 1998-04-24 1999-04-20 composto intermediário na preparação de inibidores de cox-2
BRPI9909844-0A BR9909844B1 (pt) 1998-04-24 1999-04-20 processo de preparação de compostos inibidores de cox-2.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI9917739A BRPI9917739B8 (pt) 1998-04-24 1999-04-20 composto intermediário na preparação de inibidores de cox-2

Country Status (27)

Country Link
US (2) US6040319A (pt)
EP (1) EP1071745B1 (pt)
JP (2) JP3325264B2 (pt)
KR (1) KR100414998B1 (pt)
CN (1) CN1178658C (pt)
AR (1) AR015279A1 (pt)
AT (1) ATE272613T1 (pt)
AU (1) AU759469B2 (pt)
BR (2) BRPI9917739B8 (pt)
CA (1) CA2329193C (pt)
CZ (1) CZ292515B6 (pt)
DE (1) DE69919151T2 (pt)
DK (1) DK1071745T3 (pt)
EA (1) EA002975B1 (pt)
ES (1) ES2226378T3 (pt)
HR (1) HRP20000722B1 (pt)
HU (1) HU227627B1 (pt)
IL (2) IL139127A0 (pt)
NZ (1) NZ507597A (pt)
PL (1) PL193248B1 (pt)
PT (1) PT1071745E (pt)
RS (1) RS49945B (pt)
SI (1) SI1071745T1 (pt)
SK (1) SK284805B6 (pt)
TW (1) TW474934B (pt)
UA (1) UA57143C2 (pt)
WO (1) WO1999055830A2 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861419A (en) 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
DE50009312D1 (de) * 1999-01-14 2005-02-24 Lonza Ag Verfahren zur Herstellung von 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)-phenyl]ethanon
KR100446324B1 (ko) 1999-01-14 2004-08-30 론자 아게 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법
JP2001115963A (ja) 1999-10-13 2001-04-27 Daikin Ind Ltd 圧縮機
AU776544B2 (en) * 1999-11-29 2004-09-16 Merck Canada Inc. Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-(2,3') bipyridinyl
US6858631B1 (en) 1999-11-29 2005-02-22 Merck & Co., Inc. Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl
PT1175214E (pt) * 1999-12-08 2005-04-29 Pharmacia Corp Composicoes de inibidor de ciclo-oxigenase-2 com um inicio rapido do seu efito terapeutico
JP2001261653A (ja) * 2000-03-17 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の合成法
US6521642B2 (en) 2000-05-26 2003-02-18 Merck & Co., Inc. 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis
PH12001001175B1 (en) * 2000-05-26 2006-08-10 Merck Sharp & Dohme 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis
US6800647B2 (en) 2000-05-26 2004-10-05 Merck & Co., Inc. 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
EP1299123A2 (en) * 2000-07-13 2003-04-09 Pharmacia Corporation Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
MY137736A (en) 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
CA2445502A1 (en) * 2001-05-04 2002-11-14 Merck & Co., Inc. Method and compositions for treating migraines
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
JP4700916B2 (ja) 2004-02-02 2011-06-15 富士フイルムファインケミカルズ株式会社 ピリジン誘導体の製造方法
US7271383B2 (en) * 2004-08-11 2007-09-18 Lexmark International, Inc. Scanning system with feedback for a MEMS oscillating scanner
WO2006137839A2 (en) 2004-08-24 2006-12-28 Merck & Co., Inc. Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
JP2010516679A (ja) * 2007-01-19 2010-05-20 マリンクロット インコーポレイテッド 診断用および治療用シクロオキシゲナーゼ−２結合リガンド
WO2010097802A2 (en) 2009-02-27 2010-09-02 Cadila Healthcare Limited A process for the preparation of etoricoxib
ES2683125T3 (es) 2010-06-16 2018-09-25 Glenmark Generics Limited Proceso para la preparación de piridinas 2,3-diaril-5-sustituidas y sus compuestos intermedios
CA2817939A1 (en) 2010-11-15 2012-05-24 Virdev Intermediates Pvt. Ltd. A process for cyclooxygenase-2 selective inhibitor
ITMI20110362A1 (it) * 2011-03-09 2012-09-10 F I S Fabbrica Italiana Sint P A Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
EA023286B1 (ru) 2011-05-27 2016-05-31 ФАРМА ДжРС, Д.О.О. Способ получения полиморфной формы i эторикоксиба
ITMI20111455A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Nuovo procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
CN103204803A (zh) 2012-01-13 2013-07-17 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 用于合成依托考昔的方法
ITMI20120394A1 (it) 2012-03-14 2013-09-15 Zach System Spa Processo di sintesi di un chetosolfone derivato
EP2831045A2 (en) 2012-03-30 2015-02-04 Mylan Laboratories, Limited An improved process for the preparation of etoricoxib
GR1007973B (el) * 2012-06-26 2013-09-12 Φαρματεν Αβεε, Νεα ν-οξοιμινο παραγωγα ως ενδιαμεσα μιας βελτιωμενης μεθοδου παρασκευης 2,3-διαρυλο-5-υποκατεστημενων πυριδινων
PL2887924T3 (pl) 2012-08-27 2017-09-29 Cadila Healthcare Limited Kompozycje farmaceutyczne etorykoksybu
ITVI20130014A1 (it) 2013-01-22 2014-07-23 Italiana Sint Spa Procedimento molto efficiente per preparare un intermedio di etoricoxib
WO2014114352A1 (en) * 2013-01-25 2014-07-31 Synthon Bv Process for making etoricoxib
CN104418799A (zh) * 2013-09-03 2015-03-18 天津药物研究院 一种依托考昔的晶型及其制备方法和应用
WO2015036550A1 (en) 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib
WO2016149126A1 (en) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
CN104817473A (zh) * 2015-03-27 2015-08-05 南京大学 1-二甲氨基-3-二甲亚胺基-2-氯丙烯高氯酸盐在制备依托考昔中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA988522A (en) * 1972-05-05 1976-05-04 Haydn W.R. Williams 1,8-naphthyridine compounds
DE3842062A1 (de) * 1988-12-14 1990-06-28 Hoechst Ag Explosionssichere 1-dimethylamino-3-dimethylimino-2-arylpropen-1-salze, verfahren zu ihrer herstellung und ihre verwendung
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
IL127441A (en) * 1996-07-18 2003-02-12 Merck Frosst Canada Inc Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors

Also Published As

Publication number Publication date
KR20010042941A (ko) 2001-05-25
SI1071745T1 (en) 2004-10-31
EA002975B1 (ru) 2002-12-26
HRP20000722A2 (en) 2001-06-30
EA200001102A1 (ru) 2001-04-23
HUP0101407A2 (hu) 2001-09-28
HU227627B1 (en) 2011-10-28
US6040319A (en) 2000-03-21
JP2003040852A (ja) 2003-02-13
AU759469B2 (en) 2003-04-17
DE69919151T2 (de) 2005-07-28
WO1999055830A2 (en) 1999-11-04
JP3325264B2 (ja) 2002-09-17
EP1071745B1 (en) 2004-08-04
DK1071745T3 (da) 2004-11-29
PT1071745E (pt) 2004-11-30
UA57143C2 (uk) 2003-06-16
IL139127A (en) 2006-07-05
BRPI9917739B1 (pt) 2016-05-03
CA2329193A1 (en) 1999-11-04
YU64100A (sh) 2002-11-15
KR100414998B1 (ko) 2004-01-13
SK15892000A3 (sk) 2001-07-10
WO1999055830A3 (en) 1999-12-29
NZ507597A (en) 2004-02-27
JP3834263B2 (ja) 2006-10-18
BRPI9917739B8 (pt) 2021-05-25
SK284805B6 (sk) 2005-11-03
HRP20000722B1 (hr) 2009-07-31
IL139127A0 (en) 2001-11-25
DE69919151D1 (de) 2004-09-09
RS49945B (sr) 2008-09-29
CA2329193C (en) 2007-01-23
HK1031399A1 (en) 2001-06-15
AR015279A1 (es) 2001-04-18
PL193248B1 (pl) 2007-01-31
AU3655799A (en) 1999-11-16
EP1071745A4 (en) 2002-05-15
US6252116B1 (en) 2001-06-26
EP1071745A2 (en) 2001-01-31
ES2226378T3 (es) 2005-03-16
ATE272613T1 (de) 2004-08-15
CN1306425A (zh) 2001-08-01
BR9909844B1 (pt) 2010-10-19
HUP0101407A3 (en) 2002-12-28
JP2002513035A (ja) 2002-05-08
TW474934B (en) 2002-02-01
PL344108A1 (en) 2001-09-24
CN1178658C (zh) 2004-12-08
CZ20003940A3 (en) 2001-06-13
CZ292515B6 (cs) 2003-10-15

Similar Documents

Publication Publication Date Title
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR9812837A (pt) Processo para fazer um composto, e, composto
DK1200418T3 (da) Nematodicide trifluorbutener
BR9914167A (pt) Composto, método de tratamento, inibição do crescimento de, ou erradicação de neoplasmas, e de doença de rim policìstico, em um mamìfero em necessidade do mesmo, composição farmacêutica, e processo para preparar o composto
BR9808923A (pt) Composto, e, processo para fazer o mesmo
BR0213481A (pt) Sondas
AP2002002387A0 (en) Method of inhibiting amyloid aggregation and imaging amyloid deposits.
BR9916615A (pt) Método para a preparação de éteres de arila
BR9808642A (pt) Processo para preparar eprosartan
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
BR0009453A (pt) Processo para a preparação de um composto
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
BR9909260A (pt) Processo para o preparo de (r)-alfa-(2,3-dimetóxifenil)-1-[2-(4-fluoro-fenil)etil]-4-pi peridinametanol
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
BR9808664A (pt) Processo para preparar eprosartan
BR0209842A (pt) Processo para a preparação de imipenem
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
BR9807785A (pt) Processo para a preparação do composto, e, composto
BR0116721A (pt) Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina
ZA200005110B (en) Process for preparing intermediates.
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
BR0315508A (pt) Processo para preparação de compostos de pirazol
BR9914775A (pt) Processo quìmico para preparação deintermediários
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/10/2010, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

Free format text: NOME ALTERADO DE: MERCK AND CO., INC.

B25A Requested transfer of rights approved

Owner name: SCHERING CORPORATION (US)

B25D Requested change of name of applicant approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

B25G Requested change of headquarter approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 19.10.2020